View Accessibility Controls Skip to main content
Young female scientist using digital tablet in lab

Glaucoma UK grants programme

Our grants are currently closed to new applications.

We will launch our next grant round at UKEGS 2026.

What are we looking for?

We want to fund the best possible research, which could lead to a demonstrable benefit for people living with glaucoma. All research must offer value for money, be ethically acceptable and present a high likelihood of a conclusive outcome.

As the UK’s only charity exclusively for people with glaucoma, it is imperative we fund research which supports and involves people with glaucoma. As part of the application process, applicants will need to state how their research will contribute to:

  • Patient and Public Involvement and Engagement (PPIE): Applicants should show how they planned to involve patients and the public in their research process, ensuring that research outcomes are relevant and beneficial to those most affected by glaucoma.
  • Equality, Diversity, and Inclusion (EDI): Proposals should outline how the research would overcome barriers such as accessing equitable care, help those most at risk of sight loss, and ensure inclusivity in its approach and potential impact.
  • Alignment with charitable objectives: Applicants must explain how their research aligns with Glaucoma UK’s objectives, particularly in terms of increasing awareness, enabling earlier diagnosis, and ensuring equitable access to effective care.  

For more information about our objectives, refer to our:

Timelines:

5 November 2025: Open to applications.

9.00am, 10 February 2026: Deadline for applications

Mid-June: Award panel meets (date TBC)

Late June: Notification of successful applications

Who can apply?

The principal applicant will usually hold a relevant post-graduate qualification and must be leading their own work. The host institution must be an established research institution, such as a university or hospital, in the UK or Republic of Ireland. Where the research project takes place outside the British Isles, the project should have demonstrable potential benefit to the British population and the NHS if applicable. Projects must start within 12 months of the award date.

How are decisions made?

Our Clinical Advisory Panel (CAP) make recommendations to the Board of Trustees about which research to fund. The CAP is comprised of experts in glaucoma, including professional and patient representatives. Panellists score applications according to standard criteria. We may also send applications to external reviewers for comment. All scores and feedback are discussed at a panel meeting, which may also involve interviewing applicants. The CAP provides recommendations to our Board, who then make the final decision on what to fund. 

This process is based on guidance provided by the Association of Medical Research Charities, of which Glaucoma UK is an introductory member.  

Supporting documents:

For any questions, about our research activity, email research@glaucoma.uk.

Discretionary awards

We may be able to offer small sums of money (up to £5,000) to support research projects on an ad hoc basis, where there is a clear benefit to people living with glaucoma. Read this summary document for more information.

National Institute for Health Research support

Glaucoma UK is a National Institute for Health Research (NIHR) non-commercial partner. This means the studies we fund may be eligible to access the Study Support Service provided by the NIHR Clinical Research Network. See our research grants FAQs below for further details.

A researcher standing in a lab wearing a lab coat.

Help us fund more cutting-edge research 

Can you help us fund more glaucoma research? We are entirely reliant on the generosity of our supporters, and receive no government funding. Please consider donating to help us change the outlook for people with glaucoma and make glaucoma sight loss a thing of the past.

X